Discontinuation report ACT VALSARTAN

Last updated on 2018-12-07 History
Report ID 65278
Drug Identification Number 02337495
Brand name ACT VALSARTAN
Common or Proper name VALSARTAN
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) VALSARTAN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-05-31
Remaining supply date 2018-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Transitioned. TEVA available
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-12-07 English Compare
v2 2018-10-22 French Compare
v1 2018-10-22 English Compare